Liver disease is common, often silent, and usually preventable.

"Fatty liver" describes fat build-up in the liver. MASLD (metabolic dysfunction-associated steatotic liver disease) is the current clinical term for fatty liver linked to metabolic risk factors like obesity, type 2 diabetes, or high cholesterol. MASH (metabolic dysfunction-associated steatohepatitis) is the more advanced, inflamed form of MASLD that carries a higher risk of progressing to fibrosis or cirrhosis.

In its early stages, yes — often within weeks to months. Weight loss of just 5–10% of body weight, reduced alcohol and added sugar intake, and regular exercise are all linked to measurable reductions in liver fat. Once significant scarring (fibrosis or cirrhosis) has developed, damage is generally no longer reversible, which is why early action matters.

There's no universally safe amount — risk is a spectrum, not a cliff edge. U.S. clinical guidelines describe more than 14 drinks/week (men) or 7 drinks/week (women and adults 65+) as at-risk drinking. See the Alcohol & the Liver page for the full breakdown.

The most common are ALT and AST (liver enzymes that rise with cell damage), GGT (rises with liver strain, alcohol use, and bile duct issues), and bilirubin (rises when the liver can't process waste products properly). These are usually bundled into a standard "liver function test" (LFT) panel your doctor can order.

No. It's an educational estimate based on a published research formula, not a diagnostic tool. It cannot tell you whether you have fatty liver disease — only a doctor, using proper testing such as blood work or imaging, can do that. See the Risk Calculator page for the full disclaimer.

FIB-4 (Fibrosis-4 Index) is a free calculation from four values on a routine blood panel — age, AST, ALT, and platelet count — used to estimate the likelihood of advanced liver scarring (fibrosis). A low score makes advanced scarring unlikely; a high score doesn't diagnose it, but is usually a reason a doctor orders further testing, like elastography. Try the calculator on the Risk Calculator page.

APRI (AST-to-Platelet Ratio Index) is another free, non-invasive score — calculated from AST and platelet count — that estimates the likelihood of significant liver fibrosis. It's often used alongside FIB-4 rather than instead of it, since the two scores can disagree at the edges. Neither is a diagnosis on its own; both are screening tools that help a doctor decide whether more testing is warranted.

It varies a lot by ingredient. Some, like vitamin E and omega-3s, have real clinical trial evidence in specific contexts, usually under medical supervision. Others, especially some herbal "detox" products, have weak evidence and in rare cases have themselves been linked to liver injury. See the Supplements and Medication Safety pages for specifics.

Yes, in rare cases — this is called drug-induced liver injury (DILI), and it can happen even at correct doses due to individual sensitivity. It's uncommon, which is why it's not a reason to stop necessary medication on your own, but it's also why doctors periodically order liver bloodwork for certain drugs.

See the When to See a Doctor page for a full decision guide — but as a rule, any yellowing of skin or eyes, dark urine, abdominal swelling, or unexplained easy bruising warrants prompt medical attention, not a wait-and-see approach.

No single drink "repairs" the liver — that's not how liver healing works. The closest thing to real evidence is coffee: several studies link regular black coffee (2–3+ cups a day) to lower liver enzymes and a reduced risk of fibrosis progression in people with existing liver disease, though it's not a treatment on its own. Plain water supports overall health but has no special liver-repair effect, and "detox" juices and teas marketed as liver cleanses have no clinical evidence behind them. The real driver of liver recovery is removing the cause of damage, not any specific beverage.

No single "superfood" does the work alone, but the pattern with real evidence behind it looks like coffee, olive oil, nuts (almonds, walnuts), oily fish, leafy greens, oats, and legumes — broadly, a Mediterranean-style diet, which is what most fatty liver dietary guidelines actually recommend. These foods are linked to lower liver fat and inflammation, mainly by helping with weight management and reducing the saturated fat and added sugar that drive fat buildup in the first place — not through any special detoxifying property. See the Diet page for a full breakdown.

There isn't a fast way, and it's reasonable to be wary of anything that claims otherwise. The liver does have real regenerative capacity, but the timeline depends entirely on what's being reversed: early fatty liver can measurably improve within weeks to a few months of weight loss and cutting alcohol, and early-stage fibrosis can reverse if the underlying cause is addressed soon enough — but cirrhosis, permanent scarring, generally doesn't reverse. The honest answer is that removing the cause as early as possible matters far more than any single remedy.

No credible clinical evidence supports commercial liver detox or cleanse products — this is a case where the marketing is well ahead of the science. Your liver already detoxifies your blood continuously, which is its job, and cleanse products aren't FDA-regulated, so they're not required to prove they work. Some ingredients used in "detox" blends have themselves, in rare cases, been linked to liver injury. What's actually shown to support liver health is much less exciting: limiting alcohol, maintaining a healthy weight, and avoiding unnecessary supplements.

Elevated ALT or AST usually means liver cells are inflamed or under strain and leaking these enzymes into the bloodstream at a higher rate than normal — it's a sign something is affecting the liver, not a diagnosis of what. Causes range from mild and temporary (a new medication, a recent bout of heavy drinking, even intense exercise) to ongoing conditions like fatty liver, viral hepatitis, or autoimmune disease. Mildly elevated enzymes found on a routine panel are common and often resolve on their own, but persistent or significantly elevated results are worth following up on with a doctor.

Liver-related discomfort is typically felt in the upper right side of the abdomen, just under the rib cage — often described as a dull ache or a feeling of fullness or pressure rather than sharp pain. It's worth knowing that a lot of liver disease causes no pain at all until fairly advanced, since the liver itself has few pain-sensing nerves; what people usually feel is the liver's outer capsule stretching from swelling or inflammation. Persistent pain in this area, especially alongside jaundice, fever, or dark urine, is a reason to see a doctor rather than wait it out.

It depends heavily on what's being healed from, and there's no single timeline. Fatty liver can show measurable improvement within a few months of sustained weight loss and reduced alcohol intake. Fibrosis (early scarring) can also reverse, but generally takes longer and only if the underlying cause is removed early. Cirrhosis is different — the scar tissue is largely permanent, though even at this stage, treating the underlying cause can stop further damage and sometimes allow partial recovery of function. In every case, earlier intervention means a better and faster outcome.

An enlarged liver (hepatomegaly) isn't a diagnosis on its own — it's a sign something else is going on. Causes range widely: liver conditions like fatty liver disease, hepatitis, or cirrhosis; conditions elsewhere in the body like heart failure or certain cancers; and inherited conditions like hemochromatosis (iron overload) or Wilson's disease (copper overload). It often causes no symptoms and is found incidentally on a scan or exam, though when symptoms do appear they can include abdominal discomfort, fatigue, or jaundice. Because the causes range from mild to serious, it's always worth having a doctor investigate rather than assuming.

No — this is one of the more persistent myths about liver disease. Cirrhosis has two broad stages: compensated cirrhosis, where the liver has permanent scarring but still functions well enough that many people feel fine and can live for years, sometimes without knowing they have it; and decompensated cirrhosis, where the liver can no longer keep up and serious complications appear. What determines the outcome is mostly whether the underlying cause is treated and whether progression to decompensation can be prevented — which is exactly why early detection through tools like FIB-4 or APRI matters.

They're three different viruses that share a name but not much else. Hepatitis A spreads through contaminated food or water, doesn't cause chronic infection, and resolves on its own — a vaccine prevents it. Hepatitis B spreads through blood, sexual contact, or from mother to child; adults often clear it, but infants and children infected with it are far more likely to develop lifelong chronic infection, and a vaccine is routinely given to infants. Hepatitis C spreads mainly through blood-to-blood contact, like shared needles, has no vaccine, and over half of new infections become chronic — but modern antiviral treatment now cures more than 90% of hepatitis C cases.